CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for blood cancer patients when first treatment stops working
Disease control Not yet recruitingThis study is testing whether a combination of two targeted drugs (acalabrutinib and venetoclax) can effectively treat patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) when their cancer returns after successful first-line treatment. The trial w…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists probe how exercise fights cancer from within
Knowledge-focused Not yet recruitingThis study aims to understand why strength training improves the health of people with various cancers. Researchers will enroll 150 patients with lung, breast, colon, blood, or lymph node cancers. Half will do supervised strength training twice a week for 12 weeks, while the othe…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: NA • Sponsor: University of Salamanca • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Scientists hunt clues in blood cancer genes
Knowledge-focused Not yet recruitingThis study aims to understand how specific genetic features in chronic lymphocytic leukemia (CLL) patients influence their response to treatment. Researchers will observe 45 newly diagnosed adult patients, collecting their medical history, physical exam results, and detailed lab …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC